Key result
Testosterone replacement therapy normalizes testosterone and induces full pubertal maturity following pacemaker implantation.
Why the study?
Testosterone deficiency in hypogonadotropic hypogonadism may influence cardiovascular function, and the potential interplay between hypogonadotropic hypogonadism and bradycardia remains to be explored.
Case Report (n=1)
No
This case report highlights a potential bidirectional relationship between sick sinus syndrome and reversible functional hypogonadotropic hypogonadism in a young male, suggesting that endocrine evaluation should be considered in young patients presenting with unexplained severe bradycardia and delayed puberty.
Answers are grounded in this paper and cite their sources.
Supports hypothesis of reversible hypogonadism-sick sinus link; leaves open causality and should not change practice.
Background: Hypogonadotropic hypogonadism (HH) is an endocrine disorder characterized by insufficient gonadotropin secretion, leading to low testosterone levels in men and delayed or absent puberty. While primarily affecting reproductive and sexual development, testosterone deficiency may also influence cardiovascular function. This case report explores the potential interplay between HH and bradycardia.Clinical Summary: In order to explore this potential link, we reviewed current literature on functional HH and its systemic manifestations, with particular attention to cardiovascular involvement. Additionally, we describe a clinical case encountered in our practice involving a 21-year-old male presenting with delayed puberty, marked fatigue, bradycardia, and significant weight loss. Cardiac evaluation revealed sick sinus syndrome (SSS) requiring dual-chamber pacemaker implantation, while hormonal assessment confirmed HH. Testosterone replacement therapy (TRT) was initiated, leading to full pubertal progression. Over time, the hormonal function normalized, allowing cessation of TRT without recurrence of hypogonadal symptoms – thus suggesting a reversible, functional form of HH. Findings from this case were considered alongside similar reports and physiological studies addressing androgen effects on the cardiac function.Discussion: This case illustrates of a functional and reversible form of HH. While chronic bradycardia has not been previously reported as a cause of functional HH, the pathophysiological mechanism – namely, chronic low cardiac output, is known to impair hormonal regulation. The co-occurrence of bradycardia and HH suggests a link between androgen deficiency and cardiac electrical system impairment, with this link being possibly bidirectional, as supporting literature highlights the role of testosterone in cardiac repolarization and myocardial performance.Conclusions: It is important to recognize the complexity of androgen regulation, as well as multisystemic effects of testosterone deficiency, including its potential impact on the cardiac rhythm. Conversely, in young males with unexplained bradycardia and pubertal delay, functional HH should be considered. Persistent bradycardia may itself contribute to the development of functional HH, highlighting likely a bidirectional relationship between the two diseases. Further research is therefore essential to better understand this two-way interaction and its clinical implications for both cardiovascular health and hormonal balance in younger populations.
No takes yet. Share an insight, caveat, or question.
Jociutė et al. (2026) conducted a case report in Functional hypogonadotropic hypogonadism and sick sinus syndrome (n=1). Testosterone undecanoate and dual-chamber (DDDR) pacemaker implantation was evaluated on Pubertal progression, hormonal normalization (testosterone, LH, FSH), and cardiac rhythm stability. Testosterone replacement therapy for 4 years normalized serum testosterone from 3.29 to 12.3-13.83 nmol/L and induced full pubertal maturity (Tanner P5, G5) after dual-chamber pacemaker implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: